Compound Danshen dripping pills
Function and Efficacy
Pharmacodynamic tests show that this product can improve the ischemic electrocardiogram of rats caused by vasopressin, reduce the platelet aggregation rate in vitro, increase the coronary flow of isolated rat hearts, and relax the contraction of rabbit aorta strips and pig coronary artery rings induced by K. This product can increase the maximum deformation index of red blood cells in rats with hyperviscosity caused by dextran. This product can reduce blood lipids, red blood cell membrane cholesterol content, and whole blood viscosity in dogs with hyperlipidemia model, and increase the red blood cell deformation index, red blood cell electrophoresis rate, and red blood cell membrane fluidity. This product can reduce the increased whole blood viscosity, whole blood reduced viscosity, platelet adhesion rate, and thrombosis index in rats with hyperlipidemia model. It can reduce triglycerides, cholesterol, and low-density lipoprotein in rabbits with hyperlipidemia model.
Ingredients
Appearance
This product is brown film-coated pellets, which appear yellow-brown to brown after removing the coating; it has a fragrant smell and a slightly bitter taste.
Usage and Dosage
Orally or sublingually. 10 pills each time, 3 times a day, 4 weeks as a course of treatment; or follow the doctor's advice.
Adverse Reactions
Gastrointestinal discomfort may occur occasionally.
Precautions
Not yet clear.
Drug Interactions
1. This product was tested on rats with myocardial ischemia, and it was found that it significantly improved the abnormal electrocardiogram caused by the posterior pituitary gland, indicating that it has a protective effect on myocardial ischemia. 2. In addition, the effect of this product on the coronary flow of rats was observed, and the results showed that it could significantly increase the coronary flow.
Storage
Drug cool storage area (below 20℃)
Packaging Specification
Each pill weighs 25 mg; each film-coated pill weighs 27 mg
Validity Period
48 months
Manufacturer
Tasly Pharmaceutical Group Co., Ltd.
-
Founded in:
1998-04-30 -
Address:
No. 2, Pujihe East Road, Beichen District, Tianjin (Tasly Modern Chinese Medicine City) -
Tax NO.:
9112000023944464XD -
Registered Funds:
1,493,950,005 yuan -
Website:
-
Email: